Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Clinical Transplantation|April 18, 2012
Ten-yr renal allograft survival of patients with antiphospholipid antibody syndromeSmita VaidyaTransplantation|April 15, 2008
Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatchesSmita VaidyaTransplantation|April 17, 2004
Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndromeSmita Vaidya, Kristine Gugliuzza, John A DallerTransplantation|January 2, 2007
Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodiesSmita Vaidya, David Partlow, Titus Barnes, et al.Clinical Transplantation|November 2, 2004
Campath and renal transplant rejectionPhilip G Thomas, Kanae Ishihara, Smita Vaidya, et al.Clinical Transplantation|July 18, 2006
Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodiesSmita Vaidya, David Partlow, Titus Barnes, et al.Human Immunology|January 15, 2008
DP reactive antibody in a zero mismatch renal transplant pairSmita Vaidya, Brant Hilson, Susan Sheldon, et al.Transplantation|December 14, 2006
Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assaySmita Vaidya, David Partlow, Brian Susskind, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 4, 2008
Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device supportScott D Lick, Smita Vaidya, Andras C Kollar, et al.Transplantation|June 15, 2007
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantationPhilip G Thomas, Kenneth J Woodside, Jacqueline A Lappin, et al.Pageof 2